Navigation Links
ApoCell's Cancer Predictive Index Helps Oncologists Select the Most,Effective Targeted Drug Therapy

HOUSTON--(BUSINESS WIRE)--Jun 7, 2007 - ApoCell, Inc. presented the results of a study conducted by researchers at the University of Chicago and ApoCell at the 2007 annual meeting of the American Society of Clinical Oncology (ASCO) held in Chicago in early June. The study showed that ApoCell's advanced pharmacodynamic biomarker assay technology provides reliable predictive data of clinical response. This study showed the benefit of treating aggressive head and neck cancer patients with a combination of targeted molecular drugs.

Cancer treatment is evolving from the use of highly toxic systemic compounds to targeted molecular drugs that are safer and faster acting because they aim only at cancer cell structures and their bio-mechanisms. Pharmacodynamics is an evolving field that encompasses the study of the biochemical and physiological effects of drugs, the mechanisms of drug action and the relationship between drug concentration and biological effect.

ApoCell has developed an analytical tool, the PDx Index(TM) (Pharmaco-Diagnostic Index), which indicates the likelihood of whether a targeted therapy will elicit a clinical response. The predictive index in this study was derived by comparing the biochemical state of a cancer cell receptor that is critical to the process of angiogenesis or vascularization of tumors. This PDx Index(TM) of patients with head and neck cancer showed a direct correlation between the drug regimen and patient response. This new technology is applicable to predicting the clinical outcome of most molecular targeted cancer drugs.

Dr. Darren Davis, ApoCell's President and CEO comments, "We have developed the PDx Index(TM) methodology to give drug developers, clinical investigators and oncologists a quantitative tool to predict effectiveness of cancer drug treatment. Recent research has demonstrated that different individuals respond differently to the same cancer drug therapy.
'"/>




Page: 1 2

Related medicine technology :

1. Breast Cancer and HER-2/neu: Diagnostic Tools for Targeted Therapy
2. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
3. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
4. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
5. Protox Announces Positive Clinical Data from Prostate Cancer Study
6. Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting Systems Success in Mouse Model Reported in Cancer Cell
7. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
8. Response Genetics Announces Publication of a Phase III Clinical Trial Demonstrating That Low Levels of ERCC-1 Help to Predict Likelihood of Response to Cisplatin-Based Therapy in Lung Cancer
9. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
10. Peer Reviewed Journal Article Indicates Repros Proellex Exhibits Potential for New Approach to the Treatment and Prevention of Breast Cancer
11. Rosetta Genomics and Weizmann Institute Scientists Identify Role of microRNA in Cancer Suppression
Post Your Comments:
(Date:7/2/2015)... FRANCISCO , July 2, 2015  The Green ... ), the world,s first HIPAA compliant mobile app that ... of farm-to-table fresh medical marijuana, announced today that their ... Unlike Eaze, Meadow and more than half a ... the last year, Loud Cannabis is unique in that ...
(Date:7/2/2015)... , July 2, 2015 Pharma ... stake in ZAO "Biocom" in Russia ... into the Russian pharmaceutical market which recorded RUB 765 billion ... pharmaceutical markets in the world in 2014 (IMS Health). For ... and expected to continue with this trend, projecting ...
(Date:7/2/2015)... CAMBRIDGE, Mass. , and DURHAM, N.C. ... Sciences , Inc. today announced its acquisition of assets ... Inc. (NYSE: PFE ) that had previously been ... Inc.  XRPro Sciences also acquired all of Pfizer,s rights ... re-launching the Icagen brand and will provide comprehensive services ...
Breaking Medicine Technology:New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2Lupin Acquires Biocom in Russia 2Lupin Acquires Biocom in Russia 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 2Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 3Icagen Re-launched through XRpro Sciences Acquisition of Pfizer Team and Technology for Ion Channel and Transporter Drug R&D 4
... July 22 Anadys Pharmaceuticals, Inc. (Nasdaq: ANDS ) announced ... July 29, 2010 , before the U.S. financial markets open. , ... Anadys will hold a conference call and webcast on ... to discuss its second quarter 2010 financial results and to provide an ...
... Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today that the Company will ... Wednesday, July 28, 2010 .  Neurocrine will then host a  live conference ... Thursday morning, July 29, 2010 at 8:30 a.m. Eastern Time ... , , ...
Cached Medicine Technology:Anadys Pharmaceuticals to Report Second Quarter 2010 Financial Results 2Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2010 Financial Results 2
(Date:7/3/2015)... (PRWEB) , ... July 03, 2015 , ... ... Lecture took place on June 25, 2015 at 1:00pm. The Association welcomed speaker ... issues pertaining to injured bicyclists and practical points of investigating these types of ...
(Date:7/3/2015)... Louis, MO (PRWEB) , ... July 03, 2015 , ... ... responsive website to replace their existing Talcum Powder Cancer Lawsuit Center website. Just as ... talcum powder lawsuit news , offering timely lawsuit updates and ovarian cancer warning ...
(Date:7/3/2015)... ... July 03, 2015 , ... First Choice Emergency Room , the ... Manzanares, MD as the new Medical Director of its Frisco facility. , “We are ... Frisco facility,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency ...
(Date:7/3/2015)... ... 2015 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh ... reveal biblical truth and expose popular lies regarding proper relationships according to the bible. ... immediately goes into the core of the subject by explaining why certain types of ...
(Date:7/3/2015)... ... 2015 , ... The Celebrity Dresses is currently running a promotion through July ... will have the opportunity to get 10% discount on orders that are over $100. ... have to use coupon codes or remember redemption codes. , There is a ...
Breaking Medicine News(10 mins):Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 2Health News:First Choice Emergency Room Announces Dr. Mariah N. Manzanares as Medical Director of Frisco, TX Facility 3Health News:Yisrayl Hawkins Explains What the Bible Really Says about Sex in New Publication This Week 2Health News:Celebrity Fashion Summer Party Dresses on sale at TheCelebrityDresses.com 2
... ... Alzheimer,s and Autism , , ... Austin, Texas (PRWEB) January 27, 2010 -- FreightWatch Security Net (FSN), a ... a tracking solution which answers a critical market need for solutions that track and ...
... , , CARDIFF, Calif. , Jan. 27 ... today that Jedi Mind,s Head of their Medical Division, Dr. ... Inc. Earlier last year, on December 7th 2009, Jedi ... join the company,s advisory board. , "Extensive independent tests ...
... January is Thyroid Awareness Month , JACKSONVILLE, Fla. , ... and feel our best. Yet many never realize that one of ... just below the neck.   , The thyroid is a small, ... affect the function of many of the body,s organs including the ...
... Frontiers of Knowledge Award in the Biomedicine category goes ... (1943, New York, United States), investigator in the Department ... was granted, in the words of the jury, "for ... receptors), the largest, most versatile and most therapeutically accessible ...
... lactation in new moms, researchers find , WEDNESDAY, Jan. ... antidepressants can cause delayed lactation in new mothers, which ... breast-feed their babies, a new study says. , The ... (SSRIs), which include such drugs as Prozac and Paxil, ...
... , ... driving design with numerical optimization, or just exploring data; accurate and efficient access to data ... ... open source platforms and develops advanced research solutions to overcome the challenges of our time, ...
Cached Medicine News:Health News:FreightWatch Security Net Launches Solution for Tracking and Rescuing Persons at Risk of Wandering 2Health News:FreightWatch Security Net Launches Solution for Tracking and Rescuing Persons at Risk of Wandering 3Health News:FreightWatch Security Net Launches Solution for Tracking and Rescuing Persons at Risk of Wandering 4Health News:Head of Jedi Mind's Medical Division Comments on Possibilities 2Health News:Head of Jedi Mind's Medical Division Comments on Possibilities 3Health News:Head of Jedi Mind's Medical Division Comments on Possibilities 4Health News:Unlocking the Secrets to a Healthier Body 2Health News:Unlocking the Secrets to a Healthier Body 3Health News:Lefkowitz, BBVA Foundation Frontiers of Knowledge Award in Biomedicine 2Health News:Lefkowitz, BBVA Foundation Frontiers of Knowledge Award in Biomedicine 3Health News:Antidepressants May Complicate Breast-Feeding 2Health News:Open Source Company Kitware Announces New Availability to its MIDAS Server to Further Research Collaboration and Open Science 2Health News:Open Source Company Kitware Announces New Availability to its MIDAS Server to Further Research Collaboration and Open Science 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: